Paper17522851
Specific features of sensorimotor cerebral cortex activity modulation by dopamine releaser amantadine.
Storozhuk VM and 1 other. Exp Brain Res, 2007. Cited by 3 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Specific features of sensorimotor cerebral cortex activity modulation by dopamine releaser amantadine. Papers, record 17522851. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17522851
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Specific features of sensorimotor cerebral cortex activity modulation by dopamine releaser amantadine.
- PubMed
Topics18
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Amantadine | Major topic |
| Dopamine | Major topic |
| Dopamine Agents | Major topic |
| Somatosensory Cortex | Major topic |
| Action Potentials | |
| Animals | |
| Behavior, Animal | |
| Cats | |
| Conditioning, Classical | |
| Electric Stimulation | |
| Excitatory Amino Acid Agonists | |
| Movement | |
| N-Methylaspartate | |
| Neurons | |
| Reaction Time | |
| Sulpiride | |
| Wakefulness | |
| gamma-Aminobutyric Acid |
Source PubMed
References36
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 5,111,993 | Dopamine: release from the brain in vivo by amantadine. | Science | 1971 | https://conductscience.org/library/papers/5111993 | PubMed |
| 2 | 14,151,624 | ANTIVIRAL ACTIVITY OF 1-ADAMANTANAMINE (AMANTADINE). | Science | 1964 | https://conductscience.org/library/papers/14151624 | PubMed |
| 3 | 16,134,735 | Effects of the dopaminergic agent and NMDA receptor antagonist amantadine on cognitive function, cerebral glucose metabolism and D2 receptor availability in chronic traumatic brain injury: a study using positron emission tomography (PET). | Brain Inj | 2005 | https://conductscience.org/library/papers/16134735 | PubMed |
| 4 | 9,852,592 | D1 receptor in interneurons of macaque prefrontal cortex: distribution and subcellular localization. | J Neurosci | 1998 | https://conductscience.org/library/papers/9852592 | PubMed |
| 5 | 5,818,715 | Amantadine in the treatment of Parkinson's disease. | JAMA | 1969 | https://conductscience.org/library/papers/5818715 | PubMed |
| 6 | 1,330,122 | Scheduling of monoaminergic neurotransmitter receptor expression in the primate neocortex during postnatal development. | Cereb Cortex | 1992 | https://conductscience.org/library/papers/1330122 | PubMed |
| 7 | 4,999,861 | Functional development of the prefrontal cortex in early life and the problem of neuronal plasticity. | Exp Neurol | 1971 | https://conductscience.org/library/papers/4999861 | PubMed |
| 8 | 3,280,212 | Clinical pharmacokinetics of amantadine hydrochloride. | Clin Pharmacokinet | 1988 | https://conductscience.org/library/papers/3280212 | PubMed |
| 9 | 2,951,618 | Basal ganglia and cerebral cortical distribution of dopamine D1- and D2-receptors in neonatal and adult cat brain. | Neurosci Lett | 1987 | https://conductscience.org/library/papers/2951618 | PubMed |
| 10 | 11,331,392 | Bidirectional dopamine modulation of GABAergic inhibition in prefrontal cortical pyramidal neurons. | J Neurosci | 2001 | https://conductscience.org/library/papers/11331392 | PubMed |
| 11 | 2,861,102 | Pharmacological changes in dopaminergic systems induced by long-term administration of amantadine. | Eur J Pharmacol | 1985 | https://conductscience.org/library/papers/2861102 | PubMed |
| 12 | 12,466,459 | Local application of dopamine inhibits pyramidal tract neuron activity in the rodent motor cortex. | J Neurophysiol | 2002 | https://conductscience.org/library/papers/12466459 | PubMed |
| 13 | 10,885,864 | Memantine in severe dementia: results of the 9M-Best Study (Benefit and efficacy in severely demented patients during treatment with memantine). | Int J Geriatr Psychiatry | 1999 | https://conductscience.org/library/papers/10885864 | PubMed |
| 14 | 8,622,768 | Localization of dopamine D4 receptors in GABAergic neurons of the primate brain. | Nature | 1996 | https://conductscience.org/library/papers/8622768 | PubMed |
| 15 | 11,746,730 | NMDA antagonist effects on striatal dopamine release: positron emission tomography studies in humans. | Synapse | 2002 | https://conductscience.org/library/papers/11746730 | PubMed |
| 16 | 1,988,631 | Imaging human brain development with positron emission tomography. | J Nucl Med | 1991 | https://conductscience.org/library/papers/1988631 | PubMed |
| 17 | 10,529,725 | Stimulation of dopa decarboxylase activity in striatum of healthy human brain secondary to NMDA receptor antagonism with a low dose of amantadine. | Synapse | 1999 | https://conductscience.org/library/papers/10529725 | PubMed |
| 18 | 12,231,439 | Dopamine modulation of activity of cat sensorimotor cortex neurons during conditioned reflexes. | Neurosci Lett | 2002 | https://conductscience.org/library/papers/12231439 | PubMed |
| 19 | 12,105,999 | Amantadine to improve neurorecovery in traumatic brain injury-associated diffuse axonal injury: a pilot double-blind randomized trial. | J Head Trauma Rehabil | 2002 | https://conductscience.org/library/papers/12105999 | PubMed |
| 20 | 16,342,625 | Dopaminergic modulation of spike activity in sensorimotor cortex neurons in a conditioned reflex. | Neurosci Behav Physiol | 2005 | https://conductscience.org/library/papers/16342625 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/17522851
GET https://conductscience.org/api/papers/v1/17522851/references?page=2